Advanced Micro Devices | 86.40 / +2.06% |
Date/Time | 03/01 / 21:59 |
Chg. / Chg.(%) | 1.74 / +2.06% |
Bid | - |
Ask | - |
Open | 85.82 |
Previous Close | 84.66 |
High | 86.50 |
Low | 83.97 |
Volume [USD] | 34,859,698.18 |
Volume [Units] | 408,281 |
Price fixings | 4088 |
ISIN | US0079031078 |
Security | AMD |
Exchange | IEX |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 86.3900 | ![]() |
32,746,181 |
Cboe US | 86.41 | ![]() |
2,315,030 |
IEX | 86.40 | ![]() |
408,281 |
London Inter.. | 84.70 | ![]() |
42,458 |
Xetra | 71.03 | ![]() |
30,516 |
TradeGate | 71.740 | ![]() |
27,483 |
Stuttgart | 71.740 | ![]() |
6,856 |
Moscow | 6,390.00 | 4,343 | |
Frankfurt | 70.7000 | ![]() |
1,650 |
gettex | 71.670 | ![]() |
1,357 |
Borsa Italia.. | 70.78 | ![]() |
1,329 |
Vienna Globa.. | 70.83 | ![]() |
1,156 |
Hannover | 71.07 | ![]() |
420 |
Hamburg | 70.40 | ![]() |
229 |
Berlin | 70.99 | ![]() |
54 |
München | 71.30 | ![]() |
1 |
Düsseldorf | 71.09 | ![]() |
0 |
Lang & Schwa.. | 71.560 | ![]() |
|
Mexico | 1,779.99 | ![]() |
4,394 |
Borsa Italia.. | 70.86 | ![]() |
2 |
News
- Adverum Announces Shortened Timelines and Clear Development Path for ADVM-022 Intravitreal Gene Therapy in Wet AMD, Reports Recent Business Progress and Fourth Quarter 2020 Financial Results
03/01/2021 / 22:00 - GlobeNewswire - Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
02/25/2021 / 15:07 - GlobeNewswire - Opthea Finalizes Study Designs and Start-up Activities for Phase 3 Pivotal Clinical Trials of OPT-302 in Wet AMD
02/24/2021 / 11:30 - GlobeNewswire - DigitalOcean Launches Premium Droplets
02/23/2021 / 17:30 - GlobeNewswire - AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials
02/23/2021 / 14:00 - GlobeNewswire
Personal area
Click on
to activate push quotes.
